2
Views
0
CrossRef citations to date
0
Altmetric
CORRESPONDANCE

Movement disorders and the treatment of schizophrenia

Page 409 | Published online: 16 Sep 2009

REFERENCES

  • Janno S, Matti H, Tuisku K, Wahlbeck K. Prevalence of neuroleptic‐induced movement disorders in chronic schizophrenic inpatients. American Journal of Psychiatry 2004; 161: 160–163
  • Ipekei S, Birsoz S. Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine. European Psychiatry 2001; 16: 259–260
  • Uzun O, Cansever A, Ozsahin A. A case of relapsed tardive dyskinesia due to olanzapine dose reduction. International Clinical Psychopharmacology 2001; 16: 369–371
  • Nelson MW, Reynolds RR, Kelly DI, Conley RR. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Clinical Neuropharmacology 2003; 26: 297–298
  • Bai YM, Yu SC, Lin CC. Risperidone for severe tardive dyskinesia: a 120 week randomised, double blind, placebo‐controlled study. Journal of Clinical Psychiatry 2003; 64: 1342–1348
  • Johnsen M, Wester K. Full remission of tardive dyskinesia following general anaesthesia. Journal of Neurology 2002; 249: 622–625

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.